Laurus Labs Limited
LAURUSLABS
Hisse Senetlerindeki Sıralama
#1746
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Hisse Fiyatı
$22.83
Son senkronizasyon: 2026-10-19
Piyasa Değeri
$12.34B
Değişim (1 gün)
0.51%
Değişim (1 yıl)
117.54%
Ülke
IN
Ticaret Laurus Labs Limited (LAURUSLABS)
Kategori
Healthcare
Laurus Labs Limited (LAURUSLABS) için gelir
Jun 2026 itibarıyla gelir TTM: $802.27M
Laurus Labs Limited şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $802.27M'dir. 2024 yılında şirketin geliri $604.54M önceki yıla göre azalma 2023 yılındaki $735.03M gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Laurus Labs Limited için 2013 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değiştir |
|---|---|---|
| 2026 (TTM) | $802.27M | 23.54% |
| 2025 | $649.39M | 7.42% |
| 2024 | $604.54M | -17.75% |
| 2023 | $735.03M | 13.05% |
| 2022 | $650.19M | -1.12% |
| 2021 | $657.55M | 74.93% |
| 2020 | $375.88M | 13.88% |
| 2019 | $330.06M | 4.51% |
| 2018 | $315.80M | 7.52% |
| 2017 | $293.70M | 9.46% |
| 2016 | $268.31M | 26.21% |
| 2015 | $212.60M | -3.94% |
| 2014 | $221.32M | 67.37% |
| 2013 | $132.24M | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 724.12% |
IN
|
